Alentis Development
- Address
- lock Available on a paid plan
Cardiovascular Diseases Research
At Alentis Development in Strasbourg, France, the clinical research portfolio includes cardiovascular diseases with a focus on sepsis-associated acute kidney injury. The studies are aimed at understanding whether a new therapy can help protect kidney function and improve outcomes in critically ill patients.
- Evaluation of treatment effects on renal function in sepsis-associated acute kidney injury
- Research into improving care for patients with acute kidney injury linked to sepsis
- Assessment of a potential therapy designed to support kidney recovery in intensive care settings
This area reflects the site’s work in intensive care medicine, with clinical studies centered on treatment effectiveness and better support for patients facing severe infection-related complications.
Psychiatry and Psychology Research
The site is also active in psychiatry and psychology, studying major depressive episode and insomnia. These trials are exploring whether chronotherapy-based approaches can reduce depressive symptoms and improve sleep-related problems in people living with mood disorders.
- Testing chronotherapeutic approaches for depressive episode with sleep disturbance
- Evaluating whether light-based and melatonin-based interventions can ease depressive symptoms
- Studying treatment options for patients with insomnia alongside mood disorders
This research focuses on whether nontraditional timing-based therapies may offer a practical way to improve both mood and sleep, broadening treatment options for patients with mental disorders.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 978 other sites in France
Therapeutic Area Benchmark — France
Select a therapeutic area to compare against other sites in France.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: France
Market Share
Country: France
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Alentis Development
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Chronotherapeutics: Active Light Therapy and Prolonged-Release Melatonin in Major Depressive Episode with Insomnia | Assistance Publique Hopitaux De Paris | Phase III | Recruiting | Jan 2026 | — |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Melatonin | 1 | Unknown | 2026-01-28 | 2026-01-28 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.